WO2025093184 - WIRKSTOFFKOMBINATIONEN AUS ALKYLAMIDOTHIAZOLEN UND GAMMA-UNDECALACTON

National phase entry:
Publication Number WO/2025/093184
Publication Date 08.05.2025
International Application No. PCT/EP2024/075750
International Filing Date 16.09.2024
Title **
[German] WIRKSTOFFKOMBINATIONEN AUS ALKYLAMIDOTHIAZOLEN UND GAMMA-UNDECALACTON
[English] ACTIVE INGREDIENT COMBINATIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND GAMMA UNDECALACTONE
[French] COMBINAISONS DE PRINCIPES ACTIFS CONSTITUÉES D'ALKYLAMIDOTHIAZOLES ET DE GAMMA UNDÉCALACTONE
Applicants **
BEIERSDORF AG
Inventors
BÜRGER, Anette
DORSCH, Sabrina
HANSSON, Sylke
Priority Data
102023210919.0   03.11.2023   DE
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1880
EPO Filing, Examination, Granting8126
Japan Filing, Examination, Granting1938
South Korea Filing, Examination, Granting1631
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 18,315

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[German] Wirkstoffkombinationen aus einem oder mehreren Alkylamidothiazolen und Gamma-Undecalacton.[English] The invention relates to active ingredient combinations consisting of one or more alkylamidothiazoles and gamma undecalactone.[French] L'invention concerne des combinaisons d'ingrédients actifs constitués d'un ou plusieurs alkylamidothiazoles et gamma undécalactone.